Clinical Trials and Research

Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer’s Disease

40-Hz DIFS™ significantly improves cognitive performance and brain connectivity in peer-reviewed clinical trial...

FDA Grants Breakthrough Status to CND Life Sciences’ Cutaneous Neurodiagnostic Test

The FDA's Breakthrough Devices Program is intended to expedite the development and FDA review of medical devices granted BDD...

Mytos Redefining How Regenerative Medicine is Made

Mytos, a London-based biotech startup, is tackling this bottleneck head-on with its fully automated, closed manufacturing platform...

Nutromics unveils world-first real-time in vivo multiplexing data at IATDMCT

The study, conducted in rats, demonstrated the Nutromics platform's ability to continuously track levels of multiple targets on one device ...

Siemens and Cook Medical Unlock MRI-Guided Interventions for Safer Care

A turnkey, radiation-free interventional platform designed to bring precision, safety, and real-time imaging to procedures in oncology, pediatrics, and structural heart interventions...

PHASE Scientific Pioneers Urine-Based HPV Testing to Overcome Screening Barriers

The initiative aims to demonstrate that non-invasive urine testing can match the accuracy of traditional cervical swabs while improving accessibility and compliance...

HNL Lab Medicine Introduces Self-Collected HPV Test

The self-collected option allows patients to collect their own sample in private, eliminating the need for a pelvic exam...

Philips unveils latest CT and MR innovations in radiation therapy

Philips’ new Rembra RT and Areta RT systems are designed to make cancer treatment planning faster and more accurate...

Argá Medtech’s Vision for Safer, Scalable AF Ablation

Argá Medtech, developer of the Coherent Sine-Burst Electroporation™ (CSE™) System—a next-generation PFA platform designed to expand treatment possibilities while simplifying workflows for physicians...

Olympus Initiates Global Removal of ViziShot 2 FLEX Needles Following Safety Reports

The voluntary action affects devices manufactured before May 12, 2025, after reports of component detachment linked to patient injuries and one death, with Olympus reinforcing safeguards to prioritise patient safety....